title: Potential for pharmacological manipulation of human embryonic stem cells.
abstract: The therapeutic potential of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) is vast, allowing disease modelling, drug discovery and testing and perhaps most importantly regenerative therapies. However, problems abound; techniques for cultivating self-renewing hESCs tend to give a heterogeneous population of self-renewing and partially differentiated cells and general include animal-derived products that can be cost-prohibitive for large-scale production, and effective lineage-specific differentiation protocols also still remain relatively undefined and are inefficient at producing large amounts of cells for therapeutic use. Furthermore, the mechanisms and signalling pathways that mediate pluripotency and differentiation are still to be fully appreciated. However, over the recent years, the development/discovery of a range of effective small molecule inhibitors/activators has had a huge impact in hESC biology. Large-scale screening techniques, coupled with greater knowledge of the pathways involved, have generated pharmacological agents that can boost hESC pluripotency/self-renewal and survival and has greatly increased the efficiency of various differentiation protocols, while also aiding the delineation of several important signalling pathways. Within this review, we hope to describe the current uses of small molecule inhibitors/activators in hESC biology and their potential uses in the future.
authors.affiliation: Centro de Investigacion Principe Felipe, Valencia, Spain.
authors.forename: Stuart P
authors.initials: SP
authors.lastname: Atkinson
authors.forename: Majlinda
authors.initials: M
authors.lastname: Lako
authors.forename: Lyle
authors.initials: L
authors.lastname: Armstrong
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D002454:Cell Differentiation; D015195:Drug Design; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000637:transplantation; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000637:transplantation; D044968:Regenerative Medicine / Q000379:methods*; D015398:Signal Transduction